Quick Takeaways
- Iroquois Capital Management, LLC filed SCHEDULE 13G for BriaCell Therapeutics Corp. Common Shares, no par value (BCTX).
- Disclosed ownership: 9.1%.
- Date of event: 15 Jul 2025.
Iroquois Capital Management, LLC - 15 Jul 2025 SCHEDULE 13G Report for BriaCell Therapeutics Corp. Common Shares, no par value (BCTX)
- Filing Manager
- Iroquois Capital Management, LLC
- Reporting Manager
- Richard Abbe
- Symbol
- BCTX
- Shares outstanding
- 17,582,418 shares
- Disclosed Ownership
- 1,600,000 shares
- Ownership
- 9.1%
- Form type
- SCHEDULE 13G
- Filing time
- 28 Jul 2025, 11:38:34 UTC
- Date of event
- 15 Jul 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Iroquois Capital Management, LLC disclosed 9.1% ownership in BriaCell Therapeutics Corp. Common Shares, no par value (BCTX) on 15 Jul 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 28 Jul 2025, 11:38.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Iroquois Capital Management, LLC | 3.2% | 560,000 | 0 | 560,000 | /s/ Richard Abbe | Richard Abbe, President | |
| Richard Abbe | 9.1% | 1,600,000 | 1,040,000 | 560,000 | /s/ Richard Abbe | Richard Abbe | |
| Kimberly Page | 3.2% | 560,000 | 0 | 560,000 | /s/ Kimberly Page | Kimberly Page |